Your browser doesn't support javascript.
loading
A comparison of four epidemic waves of COVID-19 in Malawi; an observational cohort study.
Anscombe, Catherine; Lissauer, Samantha; Thole, Herbert; Rylance, Jamie; Dula, Dingase; Menyere, Mavis; Kutambe, Belson; van der Veer, Charlotte; Phiri, Tamara; Banda, Ndaziona P; Mndolo, Kwazizira S; Mponda, Kelvin; Phiri, Chimota; Mallewa, Jane; Nyirenda, Mulinda; Katha, Grace; Mwandumba, Henry; Gordon, Stephen B; Jambo, Kondwani C; Cornick, Jennifer; Feasey, Nicholas; Barnes, Kayla G; Morton, Ben; Ashton, Philip M.
Afiliação
  • Anscombe C; Malawi-Liverpool-Wellcome Clinical Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi.
  • Lissauer S; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
  • Thole H; Malawi-Liverpool-Wellcome Clinical Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi.
  • Rylance J; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, United Kingdom.
  • Dula D; Malawi-Liverpool-Wellcome Clinical Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi.
  • Menyere M; Malawi-Liverpool-Wellcome Clinical Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi.
  • Kutambe B; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
  • van der Veer C; Malawi-Liverpool-Wellcome Clinical Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi.
  • Phiri T; Malawi-Liverpool-Wellcome Clinical Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi.
  • Banda NP; Malawi-Liverpool-Wellcome Clinical Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi.
  • Mndolo KS; Malawi-Liverpool-Wellcome Clinical Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi.
  • Mponda K; Institute of Life Course and Medical Sciences, University of Liverpool, Liverpool, United Kingdom.
  • Phiri C; Department of Medicine, Queen Elizabeth Central Hospital, Blantyre, Malawi.
  • Mallewa J; Kamuzu University of Health Sciences (formerly University of Malawi-College of Medicine) Blantyre, Malawi.
  • Nyirenda M; Department of Medicine, Queen Elizabeth Central Hospital, Blantyre, Malawi.
  • Katha G; Department of Medicine, Queen Elizabeth Central Hospital, Blantyre, Malawi.
  • Mwandumba H; Department of Medicine, Queen Elizabeth Central Hospital, Blantyre, Malawi.
  • Gordon SB; Kamuzu University of Health Sciences (formerly University of Malawi-College of Medicine) Blantyre, Malawi.
  • Jambo KC; Kamuzu University of Health Sciences (formerly University of Malawi-College of Medicine) Blantyre, Malawi.
  • Cornick J; Department of Medicine, Queen Elizabeth Central Hospital, Blantyre, Malawi.
  • Feasey N; Department of Medicine, Queen Elizabeth Central Hospital, Blantyre, Malawi.
  • Barnes KG; Malawi-Liverpool-Wellcome Clinical Research Programme, Kamuzu University of Health Sciences, Blantyre, Malawi.
  • Morton B; Department of Clinical Sciences, Liverpool School of Tropical Medicine, Liverpool, United Kingdom.
  • Ashton PM; Kamuzu University of Health Sciences (formerly University of Malawi-College of Medicine) Blantyre, Malawi.
medRxiv ; 2022 Jul 11.
Article em En | MEDLINE | ID: mdl-35860218
ABSTRACT

Background:

Compared to the abundance of clinical and genomic information available on patients hospitalised with COVID-19 disease from high-income countries, there is a paucity of data from low-income countries. Our aim was to explore the relationship between viral lineage and patient outcome.

Methods:

We enrolled a prospective observational cohort of adult patients hospitalised with PCR-confirmed COVID-19 disease between July 2020 and March 2022 from Blantyre, Malawi, covering four waves of SARS-CoV-2 infections. Clinical and diagnostic data were collected using an adapted ISARIC clinical characterization protocol for COVID-19. SARS-CoV-2 isolates were sequenced using the MinIONâ"¢ in Blantyre.

Results:

We enrolled 314 patients, good quality sequencing data was available for 55 patients. The sequencing data showed that 8 of 11 participants recruited in wave one had B.1 infections, 6/6 in wave two had Beta, 25/26 in wave three had Delta and 11/12 in wave four had Omicron. Patients infected during the Delta and Omicron waves reported fewer underlying chronic conditions and a shorter time to presentation. Significantly fewer patients required oxygen (22.7% [17/75] vs. 58.6% [140/239], p<0.001) and steroids (38.7% [29/75] vs. 70.3% [167/239], p<0.001) in the Omicron wave compared with the other waves. Multivariable logistic-regression demonstrated a trend toward increased mortality in the Delta wave (OR 4.99 [95% CI 1.0-25.0 p=0.05) compared to the first wave of infection.

Conclusions:

Our data show that each wave of patients hospitalised with SARS-CoV-2 was infected with a distinct viral variant. The clinical data suggests that patients with severe COVID-19 disease were more likely to die during the Delta wave.

Summary:

We used genome sequencing to identify the variants of SARS-CoV-2 causing disease in Malawi, and found that each of the four waves was caused by a distinct variant. Clinical investigation suggested that the Delta wave had the highest mortality.

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Guideline / Observational_studies Idioma: En Revista: MedRxiv Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Malauí

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Guideline / Observational_studies Idioma: En Revista: MedRxiv Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Malauí
...